FDA Inspection
Edge Pharma, LLCEdge Pharma, LLC – FDA Inspection, Jan 20, 2017
Record Details
This FDA Inspection record concerns Edge Pharma, LLC, with an inspection on January 20, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 65d0bc78-7576-43f8-8c66-997c12ec054f
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1001351
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.192Quality control unit review of records
- 21 CFR 211.46(b)Equipment for Environmental Control
- 21 CFR 211.42(c)(5)Mfg / Processing Operations Area
- 21 CFR 211.167(a)Sterility/pyrogens - test methods written, followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Edge Pharma, LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 30, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 8, 2018 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 20, 2014 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Edge Pharma, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.